Chalcone hybrids and their antimalarial activity

Malaria, one of the most striking, re-emerging infectious diseases caused by the genus Plasmodium, places a huge burden on global healthcare systems. A major challenge in the control and eradication of malaria is the continuous emergence of increasingly widespread drug-resistant malaria, creating an urgent need to develop novel antimalarial agents. Chalcone derivatives are ubiquitous in nature and have become indispensable units in medicinal chemistry applications due to their diverse biological profiles. Many chalcone derivatives demonstrate potential in vitro and in vivo antimalarial activity, so chalcone could be a useful template for the development of novel antimalarial agents. This review covers the recent development of chalcone hybrids as antimalarial agents. The critical aspects of the design and structure–activity relationship of these compounds are also discussed.     

Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy

Chronic hepatitis C virus (HCV) infection represents a major health threat to global population. In India, approximately 15–20% of cases of chronic liver diseases are caused by HCV infection. Although, new drug treatments hold great promise for HCV eradication in infected individuals, the treatments are highly expensive. A vaccine for preventing or treating HCV infection would be of great value, particularly in developing countries. Several preclinical trials of virus-like particle (VLP) based vaccine strategies are in progress throughout the world. Previously, using baculovirus based system, we have reported the production of hepatitis C virus-like particles (HCV-LPs) encoding structural proteins for genotype 3a, which is prevalent in India. In the present study, we have generated HCV-LPs using adenovirus based system and tried different immunization strategies by using combinations of both kinds of HCV-LPs with other genotype 3a-based immunogens. HCV-LPs and peptides based ELISAs were used to evaluate antibody responses generated by these combinations. Cell-mediated immune responses were measured by using T-cell proliferation assay and intracellular cytokine staining. We observed that administration of recombinant adenoviruses expressing HCV structural proteins as final booster enhances both antibody as well as T-cell responses. Additionally, reduction of binding of VLP and JFH1 virus to human hepatocellular carcinoma cells demonstrated the presence of neutralizing antibodies in immunized sera. Taken together, our results suggest that the combined regimen of VLP followed by recombinant adenovirus could more effectively inhibit HCV infection, endorsing the novel vaccine strategy.     

山东省2016-2017年人群烟草使用及其影响因素调查

目的 了解山东省人群烟草使用现状以及主要影响因素。方法 运用多阶段分层整群抽样方法,在山东省36个区（县）216个村（居委会）抽取调查对象,使用非条件logistic回归模型进行多因素分析。结果 有效调查6 271人,经过复杂加权计算后,≥ 15岁人群现在吸烟率为23.93%,其中男性为45.58%,女性为1.18%;不同年龄组人群现在吸烟率差别较大,45~64岁年龄组现在吸烟率最高（25.07%）;不同文化程度人群吸烟率不同,初中文化程度者现在吸烟率最高（28.94%）;农村现在吸烟率（24.98%）高于城市（23.08%）;现在每日吸烟率为20.23%,吸烟者开始吸烟平均年龄为21.21岁,日平均吸机制卷烟量为16.31支;在调查所有曾经和现在吸烟者中,戒烟率为20.79%。多因素logistic回归分析结果显示,性别、年龄、职业、地区、健康知识得分与吸烟行为存在关联。男性现在吸烟率高于女性（OR=49.625,95%CI：37.832~65.093）,45~64岁组现在吸烟率高于15~24岁组（OR=1.830,95%CI：1.048~3.194）,农林牧渔从业者现在吸烟率分别高于医务人员（OR=0.403,95%CI：0.187~0.866）和离退休人员（OR=0.648,95%CI：0.481~0.873）,中部地区居民现在吸烟率低于东部（OR=0.724,95%CI：0.606~0.865）,吸烟危害健康知识得分1~3分组现在吸烟率高于4~6分组（OR=1.432,95%CI：1.240~1.654）。结论 山东省人群吸烟率处于较高水平,应对吸烟者开展控烟健康教育等综合性干预措施,以降低人群吸烟率。     

山东省居民高盐饮食对死亡和期望寿命的影响

目的分析山东省居民归因高盐饮食相关疾病死亡和寿命损失。方法利用2016年山东省与原卫生部联合减盐防控高血压项目终末期评估调查获得的24 h尿钠和血压值,结合2016年全省居民死因监测数据,按照比较风险评估理论,计算各类疾病归因分值(PAF)和因高盐饮食导致死亡,利用寿命表法计算归因期望寿命损失。结果2016年山东省因高盐饮食导致死亡32987人,占相关疾病死亡的11.74%,占全部死亡的4.95%。男性因高盐死亡比例(13.51%)高于女性(9.17%)。高盐饮食导致死亡的疾病主要是心脑血管疾病(90.82%),其次为胃癌(8.10%)和慢性肾病(1.08%)。城市居民PAF(13.87%)高于农村(10.87%)。高盐饮食导致山东省居民期望寿命减少0.58岁。高盐饮食所致不同疾病对期望寿命损失作用不同,缺血性心脏病位居首位,其次为脑出血和脑梗死。结论山东省居民归因高盐饮食死亡的比例较高,心脑血管疾病是高盐饮食导致死亡的重要原因。高盐饮食严重影响山东省居民健康,还需加强减盐干预工作。     

山东省2019年中小学校教学环境调查

目的 调查山东省中小学教学环境卫生学现状。方法 2019年8月至12月,采用多阶段随机抽样方法随机抽取山东省16地市213所中小学校的1287间教室,对教学环境的教室人均面积、课桌/椅分配、黑板尺寸、教室采光、照明及噪声进行监测并计算各项指标的合格率。结果 合格率最低的是黑板面照度,为24.46%,小学、初中和高中分别为22.38%,26.24%和24.75%,差异无统计学意义。课桌椅分配符合率为31.46%,小学、初中和高中分别为25.06%,35.77%和33.59%,差异有统计学意义。教室人均面积合格率为43.52%,小学、初中和高中分别为31.32%,44.06%和55.48%,小学的合格率明显低于中学。其余项目的合格率在50%~77%之间。城区和郊县学校在教室人均面积、黑板、黑板面照度均匀度、课桌面照度和照度均匀度合格率的差异具有统计学意义,其中郊县学校的黑板面和课桌面照度均匀度合格率高于城区,其他项目合格率低于城区学校。结论 山东省中小学教学环境教室人均面积、课桌椅分配符合率和教室照明等方面还存在一些问题,需要相关部门采取措施来改善教学环境。     

山东省实施儿童风疹疫苗免疫后风疹发病年龄变化趋势的分析

目的分析山东省自1995年开始实施儿童风疹疫苗免疫后风疹发病年龄的变化趋势。方法对1999—2004年通过麻疹疫情专报系统得到的风疹疫情资料以及风疹疫苗接种情况进行分析。结果1999—2004年山东省风疹年平均报告发病率为0．59／10万，多为暴发（占总病例数的81．17％）；发病主要集中在7～15岁学龄儿童（77．77％），7岁以下发病较少（占7．93％），发病年龄中位数分别为10．37岁、11．66岁、11．41岁、12．81岁、14．28岁和13．96岁，发病高峰年龄逐年后移，成人发病有所增加；学龄前儿童风疹疫苗基础免疫估算接种率约为60％，学龄儿童约为20％。结论风疹发病年龄后移，将威胁育龄期妇女，增加发生先天性风疹综合征的危险性；应在继续做好儿童风疹免疫的同时，积极开展育龄期妇女风疹抗体筛查及疫苗接种工作。     

江苏省连云港地区新生儿苯丙酮尿症、先天性甲状腺功能低下症筛查结果分析

我国《母婴保健法》已将新生儿苯丙酮尿症(PKU)和先天性甲状腺功能低下症(CH)筛查列入法律条文。连云港市于2000年9月成立市新生儿疾病筛查中心,并于当年开展此二项疾病的筛查。结果报告如下。     

山东省6县（区）部分人群预防SARS行为调查分析

目的了解山东省不同地域居民SARS流行期生活行为及流行前后行为变化情况。方法选择城市和乡镇社区对于SARS传播和控制意义较重要的具有代表性的7个人群进行入户式现场调查。结果人们从个人卫生、公共卫生、提高身体素质、减少接触机会、维护生态平衡等多个方面约束或改进了个人行为。92.0%的被调查者认为非典流行促使自己改进了生活习惯。结论山东省人群非典期间采取预防行为的比率很高,为今后SARS、禽流感及其他呼吸道传染病的预防奠定了良好的基础。     

Whole genome alignment based one-step real-time RT-PCR for universal detection of avian orthoreoviruses of chicken,pheasant and turkey origins

Newly emerging avian orthoreovirus (ARV) variants have been continuously detected in Pennsylvania poultry since 2011. In this paper, we report our recent diagnostic assay development of one-step real-time RT-PCR (rRT-PCR) for the rapid and universal detection of all ARVs or reference strains of chicken, pheasant and turkey origins and six σC genotypes of the newly emerging field ARV variants in Pennsylvania (PA) poultry. Primers and probes for the rRT-PCR were designed from the conserved region of the M1 genome segment 5′ end based on the whole-genome alignment of various ARV strains, including six field variants or novel strains obtained in PA poultry. The detection limit of the newly developed rRT-PCR for ARV was as low as 10 copies/reaction of viral RNA, and 10^0.50–10^0.88 tissue culture infectious dose (TCID₅₀)/100 μL of viruses. This new rRT-PCR detected all six σC genotypes from the 66 ARV field variant strains and reference strains tested in this study. There were no cross-reactions with other avian viruses. Reproducibility of the assay was confirmed by intra- and inter-assay tests with variability from 0.12% to 2.19%. Sensitivity and specificity of this new rRT-PCR for ARV were achieved at 100% and 88%, respectively, in comparison with virus isolation as the “gold standard” in testing poultry tissue specimen.